EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

DNA methylases for site-selective inhibition of type IIS restriction enzyme activity

Carol N Flores-Fernández, Da Lin, Katherine Robins, Chris A O'Callaghan

Applied Microbiology and Biotechnology · 2024

DOI: 10.1007/s00253-024-13015-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Applied Microbiology and Biotechnology, 2024. Verfasst von Carol N Flores-Fernández und 3 weiteren Autor:innen. Beteiligte Einrichtung: Wellcome Trust Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Roosevelt Drive, Oxford, OX3 7BN, UK. Hauptthemen laut MEDLINE: DNA Methylation, Escherichia coli. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Biotechnology and Biological Sciences Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

DNA methylases of the restriction-modifications (R-M) systems are promising enzymes for the development of novel molecular and synthetic biology tools. Their use in vitro enables the deployment of independent and controlled catalytic reactions. This work aimed to produce recombinant DNA methylases belonging to the R-M systems, capable of in vitro inhibition of the type IIS restriction enzymes Bsa I, Bpi I, or Lgu I. Non-switchable methylases are those whose recognition sequences fully overlap the recognition sequences of their associated endonuclease. In switch methylases, the methylase and endonuclease recognition sequences only partially overlap, allowing sequence engineering to alter methylation without altering restriction. In this work, ten methylases from type I and II R-M systems were selected for cloning and expression in E. coli strains tolerant to methylation. Isopropyl β-D-1-thiogalactopyranoside (IPTG) concentrations and post-induction temperatures were tested to optimize the soluble methylases expression, which was achieved with 0.5 mM IPTG at 20 °C. The C-terminal His6-Tag versions showed better expression than the N-terminal tagged versions. DNA methylation was analyzed using purified methylases and custom test plasmids which, after the methylation reactions, were digested using the corresponding associated type IIS endonuclease. The non-switchable methylases M2. Eco 31I, M2. Bsa I, M2. Hpy AII, and M1. Mbo II along with the switch methylases M. Osp 807II and M2. Nme MC58II showed the best activity for site-selective inhibition of type IIS restriction enzyme activity. This work demonstrates that our recombinant methylases were able to block the activity of type IIS endonucleases in vitro , allowing them to be developed as valuable tools in synthetic biology and DNA assembly techniques. Key points • Non-switchable methylases always inhibit the relevant type IIS endonuclease activity • Switch methylases inhibit the relevant type IIS endonuclease activity depending on the sequence engineering of their recognition site • Recombinant non-switchable and switch methylases were active in vitro and can be deployed as tools in synthetic biology and DNA assembly Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA MethylationEscherichia coliIsopropyl ThiogalactosideMethyltransferasesDNA Restriction-Modification EnzymesEndonucleases

Stichwörter der Autor:innen

Blocking endonuclease activityDNA methylationNon-switchable methylasesRecombinant methylasesSwitch methylasesType IIS restriction enzymes

Substanzen

Isopropyl ThiogalactosideMethyltransferasesDNA Restriction-Modification EnzymesEndonucleases

Autor:innen und Institutionen

  • Wellcome Trust Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Roosevelt Drive, Oxford, OX3 7BN, UK.
  • Current address: Triple Helix Biotechnology Ltd, Moneta Building (B280), Babraham Research Campus, Babraham, Cambridge, CB22 3AT, UK.
  • Current address: Complete Regulatory, 19-20 King Edward Street, Macclesfield, SK10 1AQ, UK.
  • Wellcome Trust Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Roosevelt Drive, Oxford, OX3 7BN, UK. chris.ocallaghan@ndm.ox.ac.uk.

Förderung

  • Medical Research Council
  • Biotechnology and Biological Sciences Research Council

Zitieren

APA

Flores-Fernández, C. N., Lin, D., Robins, K., & O'Callaghan, C. A. (2024). DNA methylases for site-selective inhibition of type IIS restriction enzyme activity. Applied Microbiology and Biotechnology. https://doi.org/10.1007/s00253-024-13015-7

Vancouver

Flores-Fernández CN, Lin D, Robins K, O'Callaghan CA. DNA methylases for site-selective inhibition of type IIS restriction enzyme activity. Applied Microbiology and Biotechnology. 2024. doi:10.1007/s00253-024-13015-7

BibTeX
@article{FloresFernndez2024,
  author = {Flores-Fernández, Carol N and Lin, Da and Robins, Katherine and O'Callaghan, Chris A},
  title = {DNA methylases for site-selective inhibition of type IIS restriction enzyme activity},
  journal = {Applied Microbiology and Biotechnology},
  year = {2024},
  doi = {10.1007/s00253-024-13015-7}
}
Kostenlos starten →